LONDON (Thomson Financial) - Ardana PLC, the small-cap drug developer, said it could launch its human growth hormone diagnostic secretagogue next year if final stage trials prove successful.
The company said it has started the US registration study of the drug which is in development for the diagnosis of growth hormone deficiency in adults.
